TS271 #5 MT
KMUGMCi006-B
General
Cell Line |
|
| hPSCreg name | KMUGMCi006-B |
| Cite as: | KMUGMCi006-B (RRID:CVCL_D0H8) |
| Alternative name(s) |
TS271 #5 MT
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
IMBAi021-A (TSC107J #5, TSC#14 clone 107J#5) Donor's gene variants: TSC2, TSC2 Donor diseases: Tuberous Sclerosis IMBAi022-A (TSC112#4, TSC#24 clone 112#4) Donor's gene variants: TSC2, TSC2 Donor diseases: Tuberous Sclerosis IMBAi023-A (TSC#5 clone 32S, TSCp5#32S) Donor's gene variants: TSC2, TSC2 Donor diseases: Tuberous Sclerosis IMBAi023-B (TSC#5 clone 30S, TSCp5#30S, TSC98#30S) Donor's gene variants: TSC2, TSC2, TSC2 Donor diseases: Tuberous Sclerosis |
| Last update | 16th March 2023 |
| User feedback | |
Provider |
|
| Generator | Kanazawa Medical University (KMUGMC) |
External Databases |
|
| BioSamples | SAMEA112774597 |
| Cellosaurus | CVCL_D0H8 |
| Wikidata | Q123032822 |
General Information |
|
| Publications | |
| * Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA112750648 |
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
| Was the consent voluntarily given? | Yes |
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes |
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised |
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
| How may genetic information associated with the cell line be accessed? | Open Access |
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
| Name of accrediting authority involved? | |
| Approval number | |
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
| Source cell type |
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
|
| Source cell origin |
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
| Genes | |
| Is reprogramming vector detectable? |
No |
| Methods used |
RT-PCR
|
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
No |
| Derived under GMP? |
No |
| Available as clinical grade? |
No |
Culture Conditions
| Surface coating | iMatrix |
| Feeder cells |
No |
| Passage method |
Enzymatically
TrypLE
|
| Medium |
Other medium:
Base medium: StemFit
Main protein source: Serum concentration: % |
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | No |
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| POU5F1 (OCT-4) |
Yes |
|
|
|||
| ESRRB |
Yes |
|
Differentiation Potency
In vitro directed differentiation
Microbiology / Virus Screening |
|
| Mycoplasma | Negative |
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
figure of virtual karyotype
Karyotyping method:
G-Banding
|
Other Genotyping (Cell Line) |
|
Login to share your feedback, experiences or results with the research community.